Jose L. Ossorio-Alvarez

Cadiz, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Recommendations for the prevention and treatment of adverse effects of intravesical BCG.

Recommendations for the prevention and treatment of adverse effects of intravesical BCG.

Journal: Actas urologicas espanolas

Published: March 02, 2026

Emphysematous Pyelonephritis After Embolization of a Nonfunctioning Kidney Graft.

Emphysematous Pyelonephritis After Embolization of a Nonfunctioning Kidney Graft.

Journal: Nephrology (Carlton, Vic.)

Published: January 30, 2026

Comparing Prostatype P-score and traditional risk models for predicting prostate cancer outcomes in Spain.

Comparing Prostatype P-score and traditional risk models for predicting prostate cancer outcomes in Spain.

Journal: Actas urologicas espanolas

Published: January 27, 2025

Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate-Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence.

Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate-Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence.

Journal: The Prostate

Published: January 11, 2025

Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer.

Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancer.

Journal: Actas urologicas espanolas

Published: June 05, 2024

Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancer.

Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancer.

Journal: Actas urologicas espanolas

Published: May 30, 2024

Prevalence and management of castration-resistant prostate cancer of unknown metastatic status in the real-world setting: The AfroDiTA study.

Prevalence and management of castration-resistant prostate cancer of unknown metastatic status in the real-world setting: The AfroDiTA study.

Journal: Urologic oncology

Published: April 18, 2024

Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.

Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.

Journal: Future oncology (London, England)

Published: May 24, 2023

Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' reply.

Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' reply.

Journal: Actas urologicas espanolas

Published: April 27, 2023

¿Is CRPC definition still valid in the new era of antiandrogens for mHSPC treatment?

¿Is CRPC definition still valid in the new era of antiandrogens for mHSPC treatment?

Journal: Actas urologicas espanolas

Published: February 08, 2023

A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer.

A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer.

Journal: Actas urologicas espanolas

Published: December 15, 2022

Hormone sensitive protocol for metastatic prostate cancer, an update.

Hormone sensitive protocol for metastatic prostate cancer, an update.

Journal: Actas urologicas espanolas

Published: July 22, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026